In addition to its use in managing blood sugar levels, semaglutide has also been approved for weight management under the brand name Wegovy
It's a biological enhancement, not a cosmetic paint job
Endocrine disruptor vinclozolin induced epigenetic transgenerational adult-onset disease
International pricing variations for peptide drugs can be substantial, reflecting differences in healthcare systems, regulatory requirements, and market dynamics across countries
Cost considerations without insurance (as of 2025): Wegovy (semaglutide): approximately $1,300-$1,500 per month Saxenda (liraglutide): approximately $1,300-$1,400 per month Zepbound (tirzepatide): approximately $1,000-$1,200 per month These prices reflect list prices
Semaglutide is usually administered once a week via injection, and its long-acting nature ensures a steady state of medication in your body, providing a continuous effect on blood sugar levels